Zimmer Biomet Holdings (Zimmer Biomet Holdings) EV-to-Revenue

: 4.06 (As of Today)

View and export this data going back to 2001. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Zimmer Biomet Holdings's enterprise value is $30,003 Mil. Zimmer Biomet Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $7,394 Mil. Therefore, Zimmer Biomet Holdings's EV-to-Revenue for today is 4.06.

The historical rank and industry rank for Zimmer Biomet Holdings's EV-to-Revenue or its related term are showing as below:

ZBH' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.89 Med: 4.33 Max: 7.29
Current: 4.06

During the past 13 years, the highest EV-to-Revenue of Zimmer Biomet Holdings was 7.29. The lowest was 2.89. And the median was 4.33.

ZBH's EV-to-Revenue is ranked worse than
61.14% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 2.925 vs ZBH: 4.06

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-19), Zimmer Biomet Holdings's stock price is $119.425. Zimmer Biomet Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $35.26. Therefore, Zimmer Biomet Holdings's PS Ratio for today is 3.39.

Zimmer Biomet Holdings EV-to-Revenue Historical Data

The historical data trend for Zimmer Biomet Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

4.70

6.26

4.76

4.63

4.13

Zimmer Biomet Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue																4.63	4.58	5.00	3.96	4.13

Competitive Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zimmer Biomet Holdings EV-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's EV-to-Revenue falls into.

Zimmer Biomet Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Zimmer Biomet Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	30003.215	/	7394.3
	=	4.06

Zimmer Biomet Holdings's current Enterprise Value is $30,003 Mil.
Zimmer Biomet Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,394 Mil.

Zimmer Biomet Holdings (NYSE:ZBH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Zimmer Biomet Holdings's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	119.425	/	35.264
	=	3.39

Zimmer Biomet Holdings's share price for today is $119.425.
Zimmer Biomet Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.26.

Zimmer Biomet Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (NYSE:ZBH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

ZIM:Germany ZBH:Austria

Address

345 East Main Street, Warsaw, IN, USA, 46580

Website

https://www.zimmerbiomet.com

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Executives

Syed A. Jafry	director	345 E. MAIN STREET, WARSAW IN 46580
Sreelakshmi Kolli	director	C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Christopher B Begley	director
Robert Hagemann	director	3 GIRALDA FARMS, MADISON NJ 07940
Michael W Michelson	director	2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Betsy J Bernard	director	711 HIGH STREET, DES MOINES IA 50392-0300
Arthur J Higgins	director	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Chad F Phipps	officer: Assoc. Gen. Counsel, Corp. Sec	C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Zuilen Wilfred Van	officer: Pres, Europe, M. East & Africa	345 E. MAIN STREET, WARSAW IN 46580
Paul A Stellato	officer: VP, Controller & CAO	C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sang Yi	officer: President, Asia Pacific	345 E. MAIN STREET, WARSAW IN 46580
Lori Winkler	officer: SVP and CHRO	345 E. MAIN STREET, WARSAW IN 46580
Rachel Ellingson	officer: SVP & CSO	345 E MAIN STREET, WARSAW K7 46580
Bryan C Hanson	director, officer: President and CEO	ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Aure Bruneau	officer: Group President	345 E. MAIN STREET, WARSAW IN 46580